| Description | 1
Day Price Change % | Market Cap | P/E  | ROE % | Div. Yield % | Long-Term
Debt to Equity | Price to Book Value | Net Profit Margin % (mrq) | Price to Free Cash Flow (mrq) |
|---|---|---|---|---|---|---|---|---|---|
| Sector: Healthcare | -0.09 | 2259.7B | 22.08 | 13.56 | 2.23 | 0.72 | 10.04 | 10.99 | 286.01 |
| Industry: Drug Manufacturers - Major (More Info) | 0.17 | 1098.6B | 16.20 | 19.60 | 3.69 | 0.47 | 9.72 | 16.80 | 152.20 |
| Companies | |||||||||
| Novartis AG (NVS) | 3.23 | 135.5B | 11.12 | 14.80 | 2.50 | 0.21 | 2.62 | 20.46 | 146.90 |
| AstraZeneca plc (AZN) | 0.43 | 67.4B | 12.38 | 38.69 | 4.10 | 1.02 | 4.58 | 19.58 | -267.50 |
| Sanofi-Aventis (SNY) | 0.78 | 96.1B | 12.43 | NA | 3.10 | 0.13 | 1.38 | 25.80 | NA |
| Glaxosmithkline plc (GSK) | -2.55 | 125.4B | 13.03 | 53.12 | 4.30 | 1.11 | 7.05 | 22.99 | 35.56 |
| Wyeth (WYE) | -1.62 | 59.7B | 13.38 | 26.56 | 2.50 | 0.60 | 3.09 | 20.96 | -243.19 |
| Merck & Co. Inc. (MRK) | 1.42 | 69.2B | 14.49 | 25.65 | 4.80 | 0.23 | 3.54 | 56.73 | -65.42 |
| Eli Lilly & Co. (LLY) | 0.80 | 54.6B | 14.94 | 26.54 | 3.90 | 0.32 | 3.66 | 22.14 | 118.40 |
| Johnson & Johnson (JNJ) | 0.57 | 193.5B | 16.66 | NA | 2.70 | 0.25 | 4.24 | 20.23 | NA |
| Pfizer Inc. (PFE) | -1.36 | 127.3B | 17.13 | 10.92 | 6.70 | 0.25 | 1.89 | 23.50 | -198.02 |
| Aceto Corp. (ACET) | -2.01 | 178.9M | 18.72 | 7.58 | 2.70 | 0.00 | 1.33 | 3.35 | -16.57 |
| Bristol-Myers Squibb Co. (BMY) | 1.05 | 43.8B | 20.54 | 19.46 | 5.70 | 0.61 | 4.15 | 12.76 | 51.59 |
| Abbott Laboratories (ABT) | -0.05 | 87.9B | 21.24 | NA | 2.50 | 0.73 | 4.89 | 18.07 | NA |
| WuXi PharmaTech (Cayman) Inc. (WX) | -4.00 | 1.3B | 35.87 | 23.72 | NA | 0.18 | 4.27 | 24.29 | NA |
| Chem Rx Corporation (CHRX.OB) | -1.10 | 62.1M | 39.13 | 3.02 | NA | 2.17 | 0.95 | -0.44 | -13.78 |
| APP Pharmaceuticals, Inc. (APPX) | -0.34 | 3.7B | 115.87 | 15.73 | NA | NA | NA | 6.18 | 105.34 |
| AP Pharma Inc. (APPA) | -2.86 | 41.9M | NA | -141.57 | NA | NA | 1.83 | NA | -8.25 |
| Avigen Inc. (AVGN) | 12.07 | 96.7M | NA | -43.92 | NA | 0.11 | 1.52 | NA | -18.73 |
| CPEX Pharmaceuticals, Inc. (CPEX) | 1.21 | NA | NA | NA | NA | NA | NA | -14.90 | NA |
| Evotec AG (EVTC) | -4.83 | 364.6M | NA | -36.18 | NA | 0.07 | 1.03 | -189.25 | -16.36 |
| GeoPharma Inc. (GORX) | 0.00 | 38.0M | NA | -24.84 | NA | 0.67 | 1.08 | -11.30 | -8.84 |
| HST Global, Inc. (HSTC.OB) | 21.67 | NA | NA | NA | NA | NA | NA | NA | NA |
| Inhibiton Therapeutics, Inc. (IHBT.OB) | 0.00 | 1.5M | NA | NA | NA | NA | NA | NA | -23.13 |
| Javelin Pharmaceuticals, Inc. (JAV) | -3.39 | 111.9M | NA | -177.69 | NA | NA | 4.34 | NA | -14.66 |
| Keryx Biopharmaceuticals Inc. (KERX) | 5.26 | 17.5M | NA | -177.27 | NA | NA | 1.61 | NA | -0.74 |
| Minrad International Inc. (BUF) | -5.06 | 82.6M | NA | -74.74 | NA | 0.70 | 4.26 | -26.85 | -7.56 |
| Neurologix Inc. (NRGX.OB) | 3.92 | 14.6M | NA | -51.09 | NA | NA | 0.80 | NA | -8.53 |
| Novogen Limited (NVGN) | 0.00 | 104.7M | NA | -41.62 | NA | NA | 2.59 | -140.78 | -26.74 |
| Oscient Pharmaceuticals Corp. (OSCI) | 3.55 | 20.6M | NA | NA | NA | NA | NA | -116.61 | -5.61 |
| Provectus Pharmaceuticals, Inc (PVCT.OB) | 7.87 | 48.5M | NA | -67.71 | NA | NA | 3.61 | NA | -26.48 |
| Quick-Med Technologies Inc. (QMDT.OB) | 60.00 | 12.3M | NA | NA | NA | NA | NA | -146.70 | -45.32 |
| Rigel Pharmaceuticals, Inc. (RIGL) | -5.08 | 844.9M | NA | -64.36 | NA | 0.01 | 4.46 | NA | -36.39 |
| Schering-Plough Corp. (SGP) | -1.69 | 31.1B | NA | -18.16 | 1.30 | 0.89 | 3.65 | 6.25 | 67.29 |
| Spectrum Pharmaceuticals, Inc. (SPPI) | 0.69 | 45.9M | NA | -84.94 | NA | NA | 1.11 | NA | -7.27 |
| Tetragenex Pharmaceuticals, In (TTRX.OB) | 87.50 | 7.2M | NA | NA | NA | NA | NA | NA | -78.23 |
| Vertical Health Solutions Inc. (VHSL.OB) | 0.00 | 0.3M | NA | NA | NA | NA | NA | NA | NA |
| Znomics, Inc. (ZNOM.OB) | 0.00 | 26.0M | NA | NA | NA | NA | 9.14 | NA | -50.85 |